Regulatory Affairs (RA) is often described as a compliance function, but in practice it plays a far broader and more strategic role across pharmaceutical and biotechnology development. Regulatory professionals sit at the intersection of science, law, and business—ensuring that medicines are developed responsibly, approved efficiently, and remain compliant throughout their lifecycle

This article explores the different roles within regulatory affairs, how they fit into the product lifecycle, and how responsibilities typically evolve as professionals progress in their careers.

 

What Is the Purpose of Regulatory Affairs?

At its core, regulatory affairs exists to protect public health while enabling timely patient access to safe, effective, and high-quality medicines. This involves translating complex scientific data into regulatory submissions, ensuring compliance with global regulations, and acting as the primary interface between companies and health authorities

Crucially, regulatory affairs also supports business success by shaping regulatory strategy, influencing development timelines, and helping organisations choose the most appropriate approval pathways.

 

Regulatory Affairs Across the Product Lifecycle

Regulatory responsibilities evolve as a product moves from early research through to post-approval maintenance.

Early Research and Preclinical Development

In the earliest stages, regulatory affairs helps define the regulatory framework for development. This includes:

• Advising on product classification (e.g. small molecule, biologic, advanced therapy)
• Interpreting regulatory requirements for non-clinical studies
• Ensuring compliance with Good Laboratory Practice (GLP)
• Supporting early regulatory interactions and scientific advice meetings

Decisions made at this stage—particularly around study design and manufacturing strategy—can have long-term implications for approval success.

 

Clinical Development and Clinical Trials

During clinical development, regulatory affairs becomes deeply involved in operational and strategic activities, including:

• Preparation and submission of clinical trial applications
• Management of protocol amendments and safety reporting
• Oversight of Investigator Brochures and clinical documentation
• Ensuring compliance with Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP)

A key but often underestimated responsibility is reviewing clinical documents before submission. Regulatory input at this stage can identify weaknesses that may later trigger authority questions or delays.

 

Marketing Authorisation and Approval

As products approach market entry, regulatory affairs coordinates the preparation of marketing authorisation applications using the Common Technical Document (CTD) structure. Responsibilities include:

• Integrating quality, non-clinical, and clinical data into coherent submissions
• Managing interactions with regulators during review
• Coordinating responses to authority questions
• Developing compliant product information, including prescribing information and patient leaflets

Labelling and product information are particularly critical, as they represent the legally approved position on how a medicine can be used.

 

Post-Approval and Lifecycle Management

Regulatory work does not stop at approval. Post-authorisation activities include:

• Managing variations and changes to manufacturing or labelling
• Supporting pharmacovigilance and safety updates
• Overseeing renewals, line extensions, and new indications
• Reviewing promotional materials for compliance

This phase requires close collaboration with quality, manufacturing, medical affairs, and commercial teams.

 

Key Functional Roles Within Regulatory Affairs

Most organisations structure regulatory affairs into specialist roles aligned to core activities.

Regulatory Strategy and Intelligence

Professionals in regulatory strategy:

• Develop global regulatory plans
• Interpret evolving guidelines and legislation
• Advise project teams on optimal development pathways
• Monitor regulatory changes and assess impact on portfolios

This role is highly strategic and closely linked to senior decision-making.

 

Clinical Regulatory Affairs

Clinical regulatory specialists focus on:

• Clinical trial applications and amendments
• Regulatory oversight of clinical development
• Authority interactions during trials
• Alignment of clinical strategy with regulatory expectations

They often work closely with clinical operations and safety teams.

 

CMC (Quality) Regulatory Affairs

CMC regulatory roles ensure that:

• Manufacturing processes meet regulatory standards
• Analytical methods and specifications are compliant
• Quality documentation supports approvals and post-approval changes
• Variations related to manufacturing or supply are properly managed

These roles require strong technical understanding of chemistry, manufacturing, and controls.

 

Regulatory Operations

Regulatory operations teams manage:

• Document preparation and publishing
• Electronic submissions
• Submission lifecycle tracking
• Compliance with technical submission requirements

While less visible, this function is essential for efficient regulatory execution.

 

Labelling and Artwork Compliance

Specialists in this area:

• Develop and maintain approved product information
• Ensure consistency across regions and formats
• Manage updates following variations or safety changes
• Liaise closely with marketing and medical teams

 

Career Progression in Regulatory Affairs

Regulatory affairs offers a clearly structured career path.

Entry-Level Roles

Typical titles include Regulatory Affairs Assistant or Associate. Responsibilities often involve:

• Supporting submission preparation
• Tracking regulatory activities
• Managing documentation and administrative tasks

 

Mid-Level Roles

Roles such as Regulatory Affairs Specialist or Manager typically:

• Manage defined regulatory activities or regions
• Prepare and submit applications
• Communicate directly with health authorities
• Support cross-functional teams

 

Senior and Leadership Roles

Senior professionals (Associate Director, Director, Head of Regulatory Affairs) focus on:

• Global regulatory strategy
• Complex submissions and negotiations
• Risk assessment and mitigation
• Advising senior management on regulatory impact

 

Skills Required for Success in Regulatory Affairs

Across all levels, effective regulatory professionals combine:

• Strong scientific understanding
• In-depth regulatory knowledge
• Clear written and verbal communication
• Project management capability
• Strategic and critical thinking

The ability to collaborate across disciplines is particularly important, as regulatory affairs acts as a bridge between R&D, quality, manufacturing, and commercial teams.

 

Final Thoughts

Regulatory affairs is a diverse and evolving profession that plays a central role in bringing medicines from concept to patients. Whether focused on clinical development, quality, strategy, or lifecycle management, each regulatory role contributes to ensuring that innovation is translated into safe and effective therapies.

For professionals seeking a career that combines science, strategy, and real-world impact, regulatory affairs offers both challenge and long-term opportunity.

Start Your Journey in Regulatory Affairs

Whether you’re launching your career or advancing to a strategic role, Educo Life Sciences offers training to help you succeed in EU regulatory affairs.

👉 Explore Our EU Regulatory Courses

 

Interview with Educo Life Sciences Expert, Adriaan Fruijtier

Adriaan Fruijtier graduated as a pharmacist at the University of Utrecht, The Netherlands. Since April 2004 he has been an independent regulatory affairs consultant. Until March 2004 he was Head of the Oncology Group within Global Regulatory Affairs at Bayer AG, Wuppertal, Germany, and Bayer Corporation, West Haven, CT, USA. Between 2001 and 2003 he was Director of Regulatory Affairs at Micromet AG, a biotech company in Munich, Germany. Prior to joining Micromet he has worked during four years as a Project Manager for Oncology Projects at the European Medicines Agency in London, United Kingdom. He joined the European Medicines Agency from Novartis AG, Basel, Switzerland, where he was Regulatory Affairs Project Manager in the Oncology group in 1996 and 1997. Before 1996 he was Head of Drug Regulatory Affairs for six years at Ciba-Geigy in the Netherlands and has worked as Manager of Regulatory Affairs at Glaxo, also in the Netherlands.